ASXL2 has recently been identified as among the most commonly mutated genes in AML patients bearing the AML1-ETO fusion oncoprotein14, 15, 16 (encoded by translocation t(8;21)). The gene discussed is RUNX1T1; the disease is acute myeloid leukemia.